U.S. Residential REITs Stock News

Recent board changes at Uranium Royalty (NasdaqCM:UROY) have put governance in focus after a busy few weeks that also included fresh annual results, a new shelf registration, and a voluntary SEC deregistration. See our latest analysis for Uranium Royalty. Against this backdrop of board changes, annual results and new capital plans, Uranium Royalty’s share price has moved sharply in recent weeks, with a 30 day share price return of 50.18% and a 1 year total shareholder return of 60.70%, which...

Klaviyo, Inc. reported its second-quarter 2026 results with revenue rising to US$370.58 million, losses narrowing to US$8.85 million, raised guidance for both the third quarter and full year, and announced the acquisition of AI-native customer success firm Agency alongside ongoing share repurchases. The Agency acquisition brings co-founder Elias Torres in as Chief Product Officer to lead Klaviyo's AI agent product line, underlining the company’s focus on AI-powered customer engagement tools...

Tilley Harley-Davidson previously hosted its Freedom Revival, a 1970s-themed classic motorcycle show at its Statesville, North Carolina dealership, showcasing vintage Shovelhead and Ironhead models alongside highlighted pre-owned CVO Street Glide bikes. At the same time, Harley-Davidson’s relatively low motorcycle sales and weak free cash flow margin have drawn attention to underlying operational and financial strains. We’ll now examine how softer core motorcycle demand, and the resulting...

UroGen Pharma’s recently reported Q2 2026 results showed sales rising to US$72.46 million from US$24.22 million a year earlier, while net loss narrowed to US$14.35 million and basic loss per share improved to US$0.28. Across the first half of 2026, the company almost tripled sales to US$123.42 million and roughly halved its net loss, pointing to emerging operating leverage as revenue scales despite continued losses. We’ll now examine how this sharp revenue growth and narrowed loss profile...

Equity offering and shelf registration reshape the picture for Xenia Hotels & Resorts stock Xenia Hotels & Resorts (XHR) has just completed a US$136.9 million at the market common stock offering and filed a new US$200 million shelf registration. This provides the company with fresh funding capacity that investors will likely watch closely. See our latest analysis for Xenia Hotels & Resorts. Despite a recent pullback, with a 7 day share price return of down 7.9% and a 30 day share price return...

FedEx has recently deployed Dexterity’s dual-armed Mech robotic trailer-loading systems at its Hagerstown Hub in Maryland, automating a key part of its ground operations. This move highlights how FedEx is deepening its use of warehouse robotics to ease physically demanding work and potentially boost network efficiency. We’ll now examine how FedEx’s adoption of robotic trailer loading could influence its cost-saving DRIVE program and broader investment narrative. Invest in the nuclear...

AvalonBay Communities (AVB) has drawn fresh attention after recent share price moves, with the stock down about 4% over the past month and roughly 2% over the past 3 months. See our latest analysis for AvalonBay Communities. Against that backdrop, AvalonBay Communities has seen near term momentum fade, with recent share price returns over 7 and 30 days both in decline, while the 1 year total shareholder return of 3.3% points to a more modest longer term outcome. If you are reassessing your...

Ingevity Corporation reported past second-quarter 2026 results with sales of US$314.1 million, net income of US$35.3 million, and diluted earnings per share from continuing operations of US$1.13, alongside ongoing progress on portfolio reshaping and a completed share repurchase of 493,375 shares for US$35 million under its 2022 buyback program. The shift from a prior-year loss to profitability, combined with higher full-year adjusted EBITDA and EPS guidance, highlights management’s...

Vistance Networks (VISN) has drawn fresh attention after reporting second quarter earnings along with a special $5.00 per share cash distribution, a combination that puts both recent profit trends and capital returns in focus for shareholders. See our latest analysis for Vistance Networks. Alongside the stronger earnings and the special distribution, Vistance Networks has seen mixed share price momentum, with the share price down 37.46% year to date but a very large 3 year total shareholder...

Universal Technical Institute (UTI) is back in focus after its latest earnings update, which combined higher third quarter revenue and new student starts with a reduced fiscal 2026 outlook tied to enrollment mix and guidance revisions. See our latest analysis for Universal Technical Institute. The earnings update and lowered fiscal 2026 guidance have clearly shifted sentiment, with Universal Technical Institute’s share price falling 35.33% over the past week and 44.85% over the past month,...

With fresh tariffs on 60 key U.S. trading partners drawing a hard line on forced labor, the spotlight has swung to companies that rely more on domestic supply chains than global ones. This shift could reshape where risks and potential opportunities sit in your portfolio, especially as costs and inflation pressures ripple through. This article walks through three U.S.-focused stocks exposed to the tariff story and explains why they may warrant closer attention now. The three stocks covered...

Why Bank of New York Mellon Corporation Stock Is Back in Focus Bank of New York Mellon Corporation (BNY) is back on investors’ radar after fresh moves in digital assets, including a new staking partnership with Galaxy Digital and the rollout of tokenized fund and transfer agency capabilities. See our latest analysis for Bank of New York Mellon. Alongside these digital asset moves, the BNY share price has been firm, with a 1-month share price return of 4.94% and a 90-day share price return of...

MoonLake Immunotherapeutics reported second-quarter 2026 results, posting a net loss of US$61.81 million (US$0.84 basic loss per share) and announcing that its Phase 3 IZAR-1 trial of sonelokimab in biologic-naïve adults with active psoriatic arthritis met all clinical endpoints at Week 16. The trial’s topline data showed clinically meaningful improvements across joint, skin and quality-of-life measures, reinforcing sonelokimab’s potential to address multiple manifestations of psoriatic...

In late July 2026, Antero Resources Corporation reported higher second-quarter 2026 revenue of US$1,559.84 million and net income of US$278.66 million, alongside record production and lower impairments compared with the prior year. The company also raised its full-year 2026 production guidance and continued its share repurchase program, signaling management confidence backed by stronger operating performance and recent acquisitions. We’ll now examine how Antero’s upgraded 2026 production...

In the second quarter of 2026, APA Corporation reported lower oil, gas, and NGL production volumes and a revenue decline to US$2,399 million compared with a year earlier, but higher net income of US$747 million and earnings per share from continuing operations. Despite reduced output and sales, the company’s improved profitability suggests that cost discipline and operational efficiency are increasingly important drivers of its financial performance. With APA’s latest quarter showing higher...

ICU Medical (ICUI) raised its 2026 earnings guidance after releasing second quarter results on 6 August 2026, indicating higher expected GAAP net income and diluted EPS for the full year. See our latest analysis for ICU Medical. ICU Medical’s latest guidance hike comes after a strong run in the stock, with a 30 day share price return of 18.13% and a 1 year total shareholder return of 68.75%. This suggests momentum has been building as investors reassess growth potential and risk. If this kind...

Oil price volatility is back in focus as markets weigh the risk of supply disruption around key shipping routes. That directly affects inflation expectations and interest rate paths, which can reshape how investors think about future earnings. In this backdrop, companies that analysts expect to grow earnings strongly while keeping balance sheets in good shape stand out. This article highlights three stocks from the Healthy high growth potential screener that fit that profile. The stocks...

Sphere Entertainment Co. has reported its second-quarter 2026 results, with sales rising to US$313.64 million from US$282.68 million a year earlier, while swinging from net income of US$151.82 million to a net loss of US$38.79 million. Despite higher revenue for both the quarter and first half of 2026, the move from earnings per share above US$4.00 to a loss of US$1.07 highlights growing pressure on profitability. Next, we will examine how this shift to a quarterly net loss, despite higher...

Houlihan Lokey (HLI) recently completed a multi year share repurchase program alongside its latest quarterly results and dividend declaration. Together, these moves give you a clearer picture of how the company is currently allocating capital. See our latest analysis for Houlihan Lokey. Houlihan Lokey’s recent buyback, softer first quarter earnings and affirmed dividend come against a weaker share price backdrop, with the stock down 17.48% on a 90 day share price return and 30.03% year to...

Ormat Technologies (ORA) has drawn fresh attention after second quarter results highlighted growth in its energy storage business, improved geothermal operations, and an upgraded full year outlook supported by extended US clean energy tax credits. See our latest analysis for Ormat Technologies. Those second quarter updates and the raised 2026 guidance have coincided with a sharp near term rebound in Ormat Technologies, with a 7 day share price return of 13.96% after recent weakness. The 1...

Why Ai4 2026 Put Concentrix Back on Investor Radar Concentrix (CNXC) moved into the AI spotlight at the Ai4 2026 conference in Las Vegas, where management walked enterprise buyers through its Generative AI Playbook and showcased its proprietary iX customer experience platform. The event timing matters for investors following Concentrix stock. The company used a high profile AI forum to explain how iX connects people, data and workflows, which can shape how you think about its long term AI...

CarGurus, Inc. recently reported its second-quarter 2026 results, with sales of US$250.97 million and net income of US$49.19 million, alongside updated 2026 revenue guidance and details of a reduced-but-extended credit facility and completed share repurchase tranche. Together, stronger year-on-year profitability, longer-dated financing flexibility, and the retirement of 6.29 million shares under the February 2026 buyback provide fresh context for how management is balancing growth investment...

Why the latest earnings and dividend matter for United States Lime & Minerals investors United States Lime & Minerals (USLM) just reported second quarter 2026 results alongside a fresh quarterly dividend declaration. This gives investors new information on both the company’s recent performance and its ongoing cash return policy. On July 29, 2026, the company reported second quarter sales of US$99.13 million and net income of US$34.51 million, with diluted earnings per share from continuing...

CoreCivic (CXW) is back in focus after its second quarter update, which combined higher than expected earnings, a sharp increase in full year profit guidance linked to facility sales, and a larger share buyback authorization. See our latest analysis for CoreCivic. The recent earnings beat, higher full year profit guidance linked to facility sales, and an expanded repurchase plan appear to be feeding into a strong run for CoreCivic, with a 90 day share price return of 68.37% and a 5 year total...